作者: Seyed Ramin Radfar , Cornelis A J De Jong , Ali Farhoudian , Mohsen Ebrahimi , Parnian Rafei
DOI: 10.1101/2020.09.21.20199133
关键词:
摘要: Abstract Background The COVID-19 pandemic has impacted people with substance use disorders (SUDs) worldwide and healthcare systems have reorganized their services in response to the pandemic. Methods One week after announcement of as a pandemic, global survey, 177 addiction medicine professionals described COVID-19-related health responses own 77 countries terms SUD treatment harm reduction services. is categorized around (1) managerial measures systems, (2) logistics, (3) service providers (4) vulnerable groups. Results Respondents from over 88% reported that core medical psychiatric care for SUDs had continued; however, only 56% having any business continuity plan, and, 37.5% shortages methadone or buprenorphine supplies. Participants 41% partial discontinuation harm-reduction such needle syringe programs condom distribution. 57% overdose prevention interventions 81% outreach also been negatively impacted. Conclusions significantly globally early during Based on our findings, we provide series recommendations support be prepared more efficiently future waves similar pandemics 1) help policymakers generate plans, 2) maintain evidence-based SUDs, 3) adequate medication supplies, 4) integrate other modalities 5) specific considerations groups immigrants refugees. Highlights PWSUD globally. Addiction downgraded than psychiatry Business plan about half countries. Refugees & migrants negative impact compared Harm discontinued partially totally